Literature DB >> 6106637

Synthesis of somatostatin and [D-Trp8]-somatostatin.

A M Felix, M H Jimenez, C T Wang, J Meienhofer.   

Abstract

Experimental details for practical syntheses of somatostatin and D-Trp8-somatostatin are described. The peptides were assembled from three fragments which permit further syntheses of analogs with modifications at positions 1, 2 or 8. N alpha-Bpoc protecting groups were used for the two major fragments and these were selectively removed in the presence of the tert.-butyl derived amino acid side chain functionalities. The two cysteine residues were protected by acetamidomethyl groups. All the peptide intermediates were fully characterized and a 10-g synthesis of the protected tetradecapeptide is reported. Major fragments were coupled by the azide method in good yield. Dihydrosomatostatin and D-Trp8-dihydrosomatostatin were isolated, purified, characterized and cyclized. Polymeric side-product was successfully recycled (by reduction with dithiothreitol and reoxidation) to give an overall yield for the oxidation of 52%. Somatostatin and D-Trp8-somatostatin were purified by gel filtration or countercurrent distribution and the final products were fully characterized and determined to be > 97% pure by reversed phase high performance liquid chromatography.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6106637     DOI: 10.1111/j.1399-3011.1980.tb02911.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  2 in total

1.  Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay.

Authors:  L A Mitchell; T Zhang; M Ho; D Décarie; A J Tingle; M Zrein; M Lacroix
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

2.  Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants.

Authors:  G H Lowell; L F Smith; R C Seid; W D Zollinger
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.